1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow Epithelial Ovarian Cancer: new trials by email Literature Review of Epithelial Ovarian Cancer trials Research Report on Epithelial Ovarian Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer Niraparib - Epithelial Ovarian Cancer, Ovarian Cancer | Phase 4 | Unknown | Seoul National University Hospital | 102 | 2022-01-01 | 2022-01-26 |
Carcinoma, Ovarian Epithelial (1) · Ovarian Neoplasms (1)
Adnexal Diseases (1) · Carcinoma (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Ovarian Diseases (1)
niraparib (1)
Seoul National University Hospital (1)